March 14, 2022
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 8, 2022
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
February 22, 2022
Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022
February 22, 2022
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
February 3, 2022
Sema4 to Participate at Two Upcoming Investor Conferences in February
February 1, 2022
Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities
January 18, 2022
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
January 10, 2022
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
January 3, 2022
Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
Displaying 11 - 19 of 19